Related Experiment Video
Updated: May 2, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
ACR Appropriateness Criteria Pediatric Hodgkin Lymphoma
Stephanie A Terezakis1, Monika L Metzger, David C Hodgson
1Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital, Baltimore, Maryland.
This consensus guideline provides an evidence-based approach to the evaluation and treatment of pediatric Hodgkin lymphoma, considering long-term effects of therapy. It combines literature review and expert opinion for optimal clinical management.
Area of Science:
- Oncology
- Pediatric Hematology
- Clinical Guidelines
Background:
- Pediatric Hodgkin lymphoma is highly curable, but long-term therapy effects require careful consideration for optimal care.
- Current clinical practice necessitates standardized, evidence-based guidelines for managing this malignancy in children.
Purpose of the Study:
- To establish a consensus on the most appropriate evaluation and treatment strategies for pediatric Hodgkin lymphoma.
- To develop evidence-based guidelines incorporating current literature and expert opinion.
Main Methods:
- An expert panel convened to review the medical literature on pediatric Hodgkin lymphoma.
- The modified Delphi consensus methodology was used to rate the appropriateness of imaging and treatment procedures.
- Four clinical variants were developed to address common clinical scenarios.
Main Results:
- The guideline provides a consensus approach for the management of pediatric Hodgkin lymphoma.
- Recommendations are based on a synthesis of published literature and expert medical opinion.
- Numerical ratings and commentary are provided for imaging and treatment procedures.
Conclusions:
- This consensus guideline offers a structured approach to pediatric Hodgkin lymphoma management.
- It aims to optimize clinical care by addressing both curability and potential long-term effects of therapy.
- The guideline serves as a valuable resource for clinicians treating pediatric Hodgkin lymphoma.
More Related Videos
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism